Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 06, 2022

Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving Palbociclib Combinations for HR+/HER2− Advanced/Metastatic Breast Cancer

Cancer Treatment and Research Communications

 

Additional Info

Cancer Treatment and Research Communications
Real-world treatment patterns and clinical outcomes in patients receiving palbociclib combinations for HR+/HER2- advanced/metastatic breast cancer in Japan: Results from the IRIS study
Cancer Treat Res Commun 2022 May 06;[EPub Ahead of Print], K Mycock, L Zhan, K Hart, G Taylor-Stokes, G Milligan, C Atkinson, D Mitra

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading